| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/17/2005 | US20050038050 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 02/17/2005 | US20050038032 Quinoxaline compounds |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038016 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 02/17/2005 | US20050037997 Detoxification; hydrolases or esterases; short half-life; non-insulin dependent diabetes; side effect reduction |
| 02/17/2005 | US20050037925 Mixture with other herbicides |
| 02/17/2005 | DE10334174A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 02/17/2005 | CA2554566A1 Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534494A1 Pyrrole-based hmg-coa reductase inhibitors |
| 02/17/2005 | CA2534405A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 02/17/2005 | CA2533174A1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/17/2005 | CA2532452A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506191A1 Benzoxazine and benzoxazinone substituted triazoles |
| 02/16/2005 | EP1506179A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/16/2005 | EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 02/16/2005 | EP1505978A1 Polymorphic forms of phenyl oxazolidinone derivatives |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
| 02/16/2005 | CN1582286A Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582274A Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855714 For therapy of inflammatory, allergic, infectious or autoimmune diseases |
| 02/15/2005 | US6855713 Benzimidazole derivatives, a process for their manufacture and use as a medicine |
| 02/10/2005 | WO2005012914A2 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012294A1 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012280A1 Alkynyl aryl carboxamides |
| 02/10/2005 | WO2005012271A2 Process for the synthesis of biaryl oxazolidinones |
| 02/10/2005 | WO2005012270A2 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same |
| 02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
| 02/10/2005 | WO2005012256A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | WO2005012241A2 p-38 KINASE INHIBITORS |
| 02/10/2005 | WO2005011700A1 INHIBITORS OF Akt ACTIVITY |
| 02/10/2005 | WO2005011681A1 Chemical compounds |
| 02/10/2005 | WO2005011657A2 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | WO2005011601A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | WO2004113362A3 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | WO2003099793A9 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| 02/10/2005 | US20050033059 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050033049 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders |
| 02/10/2005 | US20050032871 Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors |
| 02/10/2005 | US20050032866 Administering N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide or salt as antiarrhythmia agent |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032861 Antibiotic (vancomycin) resistant Grampositive and Gramnegative bacteria; cycloadditon, reduction, coupling, salt formation, deprotecting, amination, oxidation |
| 02/10/2005 | US20050032859 inhibiting, in mammals, including humans, the production of A beta -peptides that can contribute to the formation of neurological deposits of amyloid protein |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032855 Tetrahydro-2H-thiopyran-4-carboxamide derivative |
| 02/10/2005 | US20050032854 Administering 2-ethoxy-1-[[2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid or a salt as a hypotensive or an antidiabetic agent; impaired glucose tolerance |
| 02/10/2005 | US20050032852 1-(N-substituted sulfonamido),4-(substituted isooxazoly-4-yl)benzenes, e.g., N-ethyl-4-(5-methyl-3-phenylisoxazol-4-yl)-N-propionylbenzenesulfonamide; side effect reduction; solubility; stability; bioavailability, i.e., readily penetrate membranes; non-steroidal antiinflammatory agents; analgesics |
| 02/10/2005 | US20050032795 2-Amino-benzoxazinones for the treatment of herpes simplex virus |
| 02/10/2005 | US20050032793 For example, 1,1-dimethylethyl [2-[[2-(diethylamino)-2-oxo-1S-(phenylmethyl)ethyl]amino]-5-methyl-4-oxo-4H-3,1-benzoxazin-6-yl]carbamate; for treating herpes-related disorders |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device |
| 02/10/2005 | US20050030912 Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field |
| 02/10/2005 | DE10331675A1 Hetarylsubstituierte Pyrazolidindion-Derivate Hetarylsubstituierte pyrazolidindione derivatives |
| 02/10/2005 | CA2534990A1 P-38 kinase inhibitors |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534464A1 Benzoxazepine compound |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2534038A1 Inhibitors of akt activity |
| 02/10/2005 | CA2533901A1 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533554A1 6-membered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | CA2533102A1 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/10/2005 | CA2532505A1 5-ht2b receptor antagonists |
| 02/10/2005 | CA2527861A1 Alkynyl aryl carboxamides |
| 02/09/2005 | EP1505067A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1503997A1 Cysteine protease inhibitors |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503991A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof |
| 02/09/2005 | EP1503986A2 Compositions and methods for treating heart failure |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1503757A2 Tyrosine kinase inhibitors |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1204322B1 Fungicides |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | EP0983999B1 Process for producing amide derivatives and intermediates |
| 02/09/2005 | EP0941093B1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |